Study Design
Subject Type
Human
Trial Design
Randomised
Trial Duration
90 days
Participants
31 (18 completed)
Age Range
18-75 years
Efficacy
Intervention(s) Outcome
Melasma
Sign in to read for free
Study Summary
Sign in to read for free